Annual Drug Patent Expirations for EXONDYS+51
Exondys 51 is a drug marketed by Sarepta Theraps Inc and is included in one NDA. It is available from one supplier. There are eleven patents protecting this drug.
Drug patent litigation for EXONDYS 51.
This drug has one hundred and eigthy-five patent family members in twenty-four countries.
The generic ingredient in EXONDYS 51 is eteplirsen. One supplier is listed for this compound. Additional details are available on the eteplirsen profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
